chenodeoxycholic acid has been researched along with cyclosporine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (30.43) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 11 (47.83) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Craddock, AL; Daniel, RW; Dawson, PA; Kirby, LC; Love, MW; Walters, HC; Wong, MH | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ericzon, BG | 1 |
| Budai, K; Javitt, NB; Levy, J | 1 |
| Bernard, B; Bouvier, E; Cabrol, A; Cadranel, JF; Dorent, R; Gandjbakhch, I; Gerhardt, M; Ghoussoub, JJ; Lunel, F; Myara, A; Opolon, P; Trivin, F | 1 |
| Angelico, M; Baiocchi, L; Casciani, CU; Iaria, G; Negrini, S; Nistri, A; Pisani, F; Romagnoli, J; Tisone, G | 1 |
| Angelin, B; Duraj, F; Einarsson, K; Ericzon, BG; Eusufzai, S; Söderdahl, G | 1 |
| Fujimura, A; Hashizume, K; Kawarasaki, H; Kobayashi, E; Mizuta, K; Uchida, H | 1 |
| Moreno, AJ; Oliveira, PJ; Palmeira, CM; Rolo, AP | 1 |
| Hishikawa, S; Kawarasaki, H; Kobayashi, E; Mizuta, K; Uchida, H | 1 |
| Gäbel, G; Honscha, KU; Honscha, W; Kneuer, C | 1 |
| Abe, T; Goto, J; Hishinuma, T; Mano, N; Mikkaichi, T; Okada, M; Shimada, M; Sugie, M; Toyohara, T; Yamaguchi, H | 1 |
| Gao, E; He, B; Koch, W; Lau, WB; Ma, XL; Pu, J; Shan, P; Wang, X; Wang, Y; Yuan, A | 1 |
| Wang, L; Zhang, FC; Zhang, X | 1 |
| Davidson, BR; Eusebi, LH; Gurusamy, KS; Saffioti, F; Thorburn, D; Tsochatzis, E | 1 |
| Fukagai, M; Ito, K; Oizumi, K; Sekine, S; Susukida, T | 1 |
| Darrer, R; Enright, EF; Gahan, CGM; Govindarajan, K; Joyce, SA; MacSharry, J | 1 |
| Kowdley, KV; Shah, RA | 1 |
4 review(s) available for chenodeoxycholic acid and cyclosporine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapeutic advances for primary biliary cholangitis: the old and the new.
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cyclosporine; Enzyme Inhibitors; Fibric Acids; Glucocorticoids; Humans; Immunosuppressive Agents; Indoles; Liver Cirrhosis, Biliary; Mesenchymal Stem Cell Transplantation; Methotrexate; Mycophenolic Acid; Pyridones; Rituximab; Tacrolimus; Ursodeoxycholic Acid; Ustekinumab | 2016 |
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Topics: Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Chronic Disease; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mitochondria; Network Meta-Analysis; Penicillamine; Quality of Life; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2017 |
Current and potential treatments for primary biliary cholangitis.
Topics: Benzothiazoles; Bezafibrate; Bile Acids and Salts; Budesonide; Case-Control Studies; Chenodeoxycholic Acid; Cholagogues and Choleretics; Clinical Trials as Topic; Cyclosporine; Disease Progression; Glucocorticoids; Homeostasis; Humans; Immunologic Factors; Immunosuppressive Agents; Isoxazoles; Liver Cirrhosis, Biliary; Liver Transplantation; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Rituximab; Treatment Outcome; United States; United States Food and Drug Administration; Ursodeoxycholic Acid | 2020 |
2 trial(s) available for chenodeoxycholic acid and cyclosporine
| Article | Year |
|---|---|
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients.
Topics: Adult; Analysis of Variance; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Cyclosporine; Female; Humans; Immunosuppressive Agents; Intestinal Absorption; Liver Transplantation; Male; Regression Analysis; Time Factors | 1996 |
Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus.
Topics: Adult; Bile; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Prospective Studies; Tacrolimus | 1997 |
17 other study(ies) available for chenodeoxycholic acid and cyclosporine
| Article | Year |
|---|---|
Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.
Topics: Amino Acid Sequence; Animals; Anions; Base Sequence; Bile Acids and Salts; Biological Transport; Carrier Proteins; Cations, Monovalent; CHO Cells; Cloning, Molecular; COS Cells; Cricetinae; DNA, Complementary; Humans; Ileum; Kidney; Kinetics; Molecular Sequence Data; Organic Anion Transporters, Sodium-Dependent; Recombinant Proteins; RNA, Messenger; Sodium; Symporters; Taurocholic Acid; Transcription, Genetic; Transfection | 1998 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Early graft function in liver transplantation patients.
Topics: Bile; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cyclosporine; Graft Rejection; Humans; Liver Transplantation; Tacrolimus; Time Factors | 1994 |
Bile acid synthesis in HepG2 cells: effect of cyclosporin.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Cyclosporine; Humans; Sterols; Tumor Cells, Cultured | 1994 |
Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cholestasis; Cholic Acid; Cholic Acids; Chromatography, High Pressure Liquid; Cyclosporine; Fasting; Female; Glycocholic Acid; Heart Transplantation; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Lithocholic Acid; Male; Middle Aged; Spectrophotometry, Ultraviolet; Taurocholic Acid; Ursodeoxycholic Acid | 1996 |
Dose-dependent reduction of bile secretion in cyclosporine-treated rats.
Topics: Animals; Bile; Chenodeoxycholic Acid; Cyclosporine; Dose-Response Relationship, Drug; Male; Rats; Rats, Wistar; Secretory Rate | 1998 |
Chenodeoxycholate is a potent inducer of the permeability transition pore in rat liver mitochondria.
Topics: Animals; Calcium; Chenodeoxycholic Acid; Cholestasis; Cyclosporine; Enzyme Inhibitors; Gastrointestinal Agents; Indicators and Reagents; Liver; Male; Membrane Potentials; Mitochondria, Liver; Osmosis; Permeability; Rats; Rats, Wistar; Ruthenium Red; Subcellular Fractions | 2001 |
Increase of bile acid production by tacrolimus in the rat liver.
Topics: Animals; Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Cyclosporine; Immunosuppressive Agents; Liver; Male; Rats; Rats, Wistar; Tacrolimus; Ursodeoxycholic Acid | 2003 |
Adaptive response to increased bile acids: induction of MDR1 gene expression and P-glycoprotein activity in renal epithelial cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile Acids and Salts; Cell Line; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholic Acid; Cyclosporine; Deoxycholic Acid; Dogs; Enzyme Inhibitors; Epithelial Cells; Gastrointestinal Agents; Gene Expression Regulation; Kidney; Paclitaxel; Rhodamine 123; Taurocholic Acid | 2007 |
Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1.
Topics: Animals; Binding, Competitive; Biological Transport; Cell Line; Chenodeoxycholic Acid; Cyclosporine; Digoxin; Dogs; Epithelial Cells; Estrone; Humans; Kidney; Organic Anion Transporters; Ouabain; Pharmacokinetics; Sulfobromophthalein; Triiodothyronine | 2010 |
Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Survival; Chenodeoxycholic Acid; Cyclosporine; Cytochromes c; Enzyme Inhibitors; Isoxazoles; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Myocardial Reperfusion Injury; Myocytes, Cardiac; Pregnenediones; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering | 2013 |
Identification of Bile Acids Responsible for Inhibiting the Bile Salt Export Pump, Leading to Bile Acid Accumulation and Cell Toxicity in Rat Hepatocytes.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; Bile Acids and Salts; Cell Death; Cells, Cultured; Chenodeoxycholic Acid; Cyclosporine; Deoxycholic Acid; Hepatocytes; Rats; Rats, Sprague-Dawley | 2017 |
Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein.
Topics: ATP Binding Cassette Transporter, Subfamily B; Biological Variation, Population; Caco-2 Cells; Cell Survival; Chenodeoxycholic Acid; Cyclosporine; Deoxycholic Acid; Drug Resistance, Multiple; Gastrointestinal Microbiome; Glycine; HT29 Cells; Humans; Intestinal Mucosa; RNA, Messenger; Taurine; Toxicity Tests | 2018 |